Xeris Biopharma Holdings, Inc.
USD6.00
-0.07 (-1.15%)
CEO
John Shannon
IPO Date
2018-06-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.96
Prev. Close
$6.07
Day Low
$5.87
Day High
$6.04
52W Low
$4.30
52W High
$10.08
Market Cap
$1.04B
Volume
1.35M
| $5.99 |
| 1 Apr 2026 | Brady James Aloysius | director | S-Sale | Disposed | 10,834 | $5.54 |
| 16 Mar 2026 | McCulloch Kevin | See Remarks | M-Exempt | Acquired | 48,894 | $4.09 |
| 16 Mar 2026 | McCulloch Kevin | See Remarks | M-Exempt | Acquired | 4 | $3.94 |
| 16 Mar 2026 | McCulloch Kevin | See Remarks | M-Exempt | Disposed | 48,894 | $4.09 |
| 16 Mar 2026 | McCulloch Kevin | See Remarks | M-Exempt | Disposed | 4 | $3.94 |
| 5 Mar 2026 | Pieper Steven | See Remarks | M-Exempt | Acquired | 27,891 | $4.09 |
| 5 Mar 2026 | Pieper Steven | See Remarks | M-Exempt | Acquired | 14,036 | $5.93 |
| 5 Mar 2026 | Pieper Steven | See Remarks | M-Exempt | Disposed | 27,891 | $4.09 |